Pharmacokinetics, Safety, and 48-Week Efficacy of Oral Raltegravir in HIV-1-Infected Children Aged 2 Through 18 YearsSharon Nachman, H. N. Ndiweni, Xin Xu et al.|Clinical Infectious Diseases|2013Cited by 60